RDY

#839
Dr. Reddy's Laboratories Limited American Depositary Shares
13.26 USD
+0.15%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
13.26
13.28
Intervallo Annuale
12.81
16.16
Variazione giornaliera
+0.15%
Variazione Mensile
-5.35%
Variazione di 6 mesi
-5.08%
Variazione Annuale
-0.60%
Chiusura Precedente
13.24
Apertura
13.26
Bid
Ask
Minimo
13.26
High
13.28
Volume
89
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 11.06 B
  • Employee 28 K
  • Founded 1984
  • CEO Erez Israeli
  • Website www.drreddys.com
  • Headquarter India
  • FIGI BBG000NJ96L6
  • Industry Technology
Ricavi totali
Utile netto
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Dr. Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr.

Notizie